Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX, page-6

  1. 494 Posts.
    my understanding is this is a typical case of the generics having a crack - Acrux has the patients and so the risk of them being struck out by the courts is low...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
0.002(12.5%)
Mkt cap ! $7.366M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $6.175K 343.2K

Buyers (Bids)

No. Vol. Price($)
4 246823 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 33394 1
View Market Depth
Last trade - 13.04pm 18/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.